RightEye Acquires Eye Movement Tests to Identify Early Stages of Autism and Parkinson's Disease

 RightEye Acquires Eye Movement Tests to Identify Early Stages of Autism and Parkinson's Disease

Health technology company RightEye LLC recently announced it has acquired exclusive rights to two internationally recognized eye movement tests to help doctors more accurately and objectively identify early stages of autism in children 12 to 40 months old, and aids in detecting Parkinson’s disease in patients of all ages.

The GeoPref Autism Test was reportedly developed by a leading researcher in understanding autism and uses eye-tracking technology to compare the amount of time children spend looking at videos of people with amount of time they look at videos of geometric shapes. And the Parkinson’s & Other Movement Disorders Test has reportedly been used to identify Parkinson's and other rare movement disorders such as Huntington’s disease and Essential Tremor in thousands of patients for more than 12 years.

Click here to read the full press release.

Source: RightEye

  • <<
  • >>

Comments